BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 14581455)

  • 1. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
    Yeo C; Whitman M
    Mol Cell; 2001 May; 7(5):949-57. PubMed ID: 11389842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
    Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
    Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
    Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
    J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC; Harrison CA; Vale W
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.
    D'Andrea D; Liguori GL; Le Good JA; Lonardo E; Andersson O; Constam DB; Persico MG; Minchiotti G
    J Cell Biol; 2008 Feb; 180(3):597-605. PubMed ID: 18268105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
    Kumar A; Novoselov V; Celeste AJ; Wolfman NM; ten Dijke P; Kuehn MR
    J Biol Chem; 2001 Jan; 276(1):656-61. PubMed ID: 11024047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
    Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
    Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.
    Harms PW; Chang C
    Genes Dev; 2003 Nov; 17(21):2624-9. PubMed ID: 14563676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
    Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
    J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
    Reissmann E; Jörnvall H; Blokzijl A; Andersson O; Chang C; Minchiotti G; Persico MG; Ibáñez CF; Brivanlou AH
    Genes Dev; 2001 Aug; 15(15):2010-22. PubMed ID: 11485994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
    Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
    Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
    Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA
    Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion.
    Sakuma R; Ohnishi Yi Y; Meno C; Fujii H; Juan H; Takeuchi J; Ogura T; Li E; Miyazono K; Hamada H
    Genes Cells; 2002 Apr; 7(4):401-12. PubMed ID: 11952836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
    Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
    Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cripto signaling in differentiating embryonic stem cells.
    Minchiotti G; Parisi S; Persico MG
    Methods Mol Biol; 2006; 329():151-69. PubMed ID: 16845990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
    FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development.
    Andersson O; Bertolino P; Ibáñez CF
    Dev Biol; 2007 Nov; 311(2):500-11. PubMed ID: 17936261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.